Q2 2023 13F Holders as of 6/30/2023
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
18.6M
-
Number of holders
-
15
-
Total 13F shares, excl. options
-
1.07M
-
Shares change
-
-612K
-
Total reported value, excl. options
-
$1.38M
-
Value change
-
-$1.38M
-
Number of buys
-
7
-
Number of sells
-
-5
-
Price
-
$1.28
Significant Holders of UNICYCIVE THERAPEUTICS, INC. - Common Stock, par value $0.001 per share (UNCY) as of Q2 2023
18 filings reported holding UNCY - UNICYCIVE THERAPEUTICS, INC. - Common Stock, par value $0.001 per share as of Q2 2023.
UNICYCIVE THERAPEUTICS, INC. - Common Stock, par value $0.001 per share (UNCY) has 15 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.07M shares
of 18.6M outstanding shares and own 5.78% of the company stock.
Largest 10 shareholders include Nantahala Capital Management, LLC (647K shares), VANGUARD GROUP INC (115K shares), GOLDMAN SACHS GROUP INC (95.9K shares), GEODE CAPITAL MANAGEMENT, LLC (66.8K shares), STATE STREET CORP (35K shares), Ground Swell Capital, LLC (20K shares), CAPTRUST FINANCIAL ADVISORS (18.8K shares), TANDEM CAPITAL MANAGEMENT CORP /ADV (15.5K shares), TWO SIGMA ADVISERS, LP (15.2K shares), and Centiva Capital, LP (15.2K shares).
This table shows the top 15 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.